118658-21-2

Upstream product

• 57959-37-2 3-O-hexadecyl-1,2-O-isopropylidene-sn-glycerol 
• 112-82-3 hexadecanyl bromide 
• 506-03-6 chimyl alcohol 
• 14470-28-1 mono-4-methoxytrityl chloride 

Downstream Products

• 82507-09-3 2-O-Acetyl-3-O-hexadecyl-1-O-(4-methoxytrityl)-sn-glycerol 
• 74389-68-7 PAF 
• 77133-35-8 2-O-Acetyl-3-O-hexadecyl-sn-glycerol 
• 82507-05-9 Acetic acid (R)-2-[(benzotriazol-1-yloxy)-(2-chloro-phenoxy)-phosphoryloxy]-1-hexadecyloxymethyl-ethyl ester 
• 82507-07-1 Toluene-4-sulfonate{2-[((R)-2-acetoxy-3-hexadecyloxy-propoxy)-(2-chloro-phenoxy)-phosphoryloxy]-ethyl}-trimethyl-ammonium; 
• 145048-71-1 Hexadecyl 2-(hexadecyloxy)-1-[[(4-methoxyphenyl) diphenylmethoxy]methyl]ethyl phosphoric acid, methyl ester 

Relevant academic research and scientific papers

Novel chemo-enzymatic synthesis of optically active platelet activating factor

This paper describes an enantioselective enzymatic synthesis of biologically active platelet activating factor (PAF) starting from chloropyruvic acid.

Phosphocholine derivative inhibitors of phospholipase A2

Phospocholine derivatives having the formula: STR1 in which W, Z, Q and R are described in the specification are disclosed as useful for inhibiting the enzyme phospholipase A2. Methods of making and using the compounds are also disclosed.